TP53 and breast cancer: Indeed, CHEK2-defective cells exhibited higher migratory and invasive capacities, expressed lower levels of p53 and higher levels of the myofibroblast markers α-SMA and SDF-1, and enhanced the migration/invasion abilities of breast cancer cells and their mesenchymal features in a paracrine manner.